Grant Thornton China's Asia Private Equity review looks specifically into the private equity activities across the region to see how private equity funds perform in Asia as compared to the global environment. It also aims to identify the key challenges facing the private equity funds across the region, and provides an outlook for future private equity activities in Asia and globally.
In this 2018 edition, we discuss the major opportunities and challenges by sector, including:
- industrial and chemicals
- pharma, medical and biotech
- energy, mining and utilities
- technology, including FinTech.
We consider the outlook for global private equity firms and compare with Chinese and Asian counterparts. We summarise the key challenges facing merger and acquisition activities this year and also compare pre-backed buyout deals by region.
Finally, we assess exit trends in Asia including IPO market trends in Hong Kong and mainland China.